Clove Capital Partners

Clove Capital Partners pursues a dual strategy of growth equity and turnaround investments from its Hong Kong base. The firm provides expansion capital to companies with established operations and also acquires or recapitalizes underperforming businesses requiring operational restructuring. This combined mandate differentiates it from most Asian middle-market private equity managers, who typically specialize in one discipline or the other.

The firm focuses on Greater China and Southeast Asia, regions where corporate carve-outs, family-business succession issues, and regulatory changes create deal flow for both growth and turnaround investing. Its Hong Kong headquarters positions it within the legal and financial infrastructure that supports cross-border transactions across the region.

Clove Capital Partners does not publicly disclose a formal fund structure, which is consistent with an independent sponsor model. This means the firm typically raises capital on a deal-by-deal basis rather than drawing from a committed blind pool. This approach offers co-investors flexibility and aligns incentives around individual transaction outcomes, but it also means the firm does not report through the conventional limited-partner disclosure cycle.

The firm executes control buyouts, structured minority investments, and turnaround special situations. Its deal types range from founder liquidity events and growth capital rounds to balance-sheet restructurings where operational intervention is the primary value-creation lever.

The firm's dual-strategy posture creates sourcing channels that single-strategy funds rarely access. Companies seeking growth capital may have turnaround needs that become apparent only during diligence, and vice versa. Clove's Hong Kong location also provides proximity to regional family offices, intermediaries, and corporate sellers who value a buyer capable of evaluating both upside and distress in the same process.